The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing
Open accessAbstract
Topoisomerase II is an essential enzyme that is required for virtually every process that requires movement of DNA within the nucleus or the opening of the double helix. This enzyme helps to regulate DNA under- and overwinding and removes knots and tangles from the genetic material. In order to carry out its critical physiological functions, topoisomerase II generates transient double-stranded breaks in DNA. Consequently, while necessary for cell survival, the enzyme also has the capacity to fragment the genome. The DNA cleavage/ligation reaction of topoisomerase II is the target for some of the most successful anticancer drugs currently in clinical use. However, this same reaction also is believed to trigger chromosomal translocations that are associated with specific types of leukemia. This article will familiarize the reader with the DNA cleavage/ligation reaction of topoisomerase II and other aspects of its catalytic cycle. In addition, it will discuss the interaction of the enzyme with anticancer drugs and the mechanisms by which these agents increase levels of topoisomerase II-generated DNA strand breaks. Finally, it will describe dietary and environmental agents that enhance DNA cleavage mediated by the enzyme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA Topoisomerases: Structure, Function, and Mechanism
Champoux, J. J. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.369 · Cited by 2,743
Cellular roles of DNA topoisomerases: a molecular perspective
Wang, J. C. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm831 · Cited by 2,353
Topoisomerase I inhibitors: camptothecins and beyond
Pommier, Y. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1977 · Cited by 2,277
Wang, J. C. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.003223 · Cited by 1,832
Galati, G., & O'Brien, P. J. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.04.034 · Cited by 1,099
Etoposide: four decades of development of a topoisomerase II inhibitor
Hande, K. R. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00228-7 · Cited by 949
Structure and mechanism of DNA topoisomerase II
Berger, J. M., Gamblin, S. J., Harrison, S. C., & Wang, J. C. (1996) · Nature · doi:10.1038/379225a0 · Cited by 859
A Topoisomerase IIß-Mediated dsDNA Break Required for Regulated Transcription
Ju, B.-G., Lunyak, V. V., Perissi, V., Garcia-Bassets, I., Rose, D. W., Glass, C. K., & Rosenfeld, M. G. (2006) · Science · doi:10.1126/science.1127196 · Cited by 840
Plasma concentrations of phyto-oestrogens in Japanese men
ADLERCREUTZ, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)92188-y · Cited by 731
(1936) · Nature · doi:10.1038/137559c0 · Cited by 694
Early steps in the DNA base excision/single-strand interruption repair pathway in mammalian cells
Hegde, M. L., Hazra, T. K., & Mitra, S. (2008) · Cell Research · doi:10.1038/cr.2008.8 · Cited by 661
Cytochrome P450s and other enzymes in drug metabolism and toxicity
Guengerich, F. P. (2006) · The AAPS Journal · doi:10.1208/aapsj080112 · Cited by 624
(1965) · Nature · doi:10.1038/208021c0 · Cited by 611
Encyclopedia of biological chemistry
(2013) · Choice Reviews Online · doi:10.5860/choice.51-0034 · Cited by 558
Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II.
Markovits, J., Linassier, C., Fossé, P., Couprie, J., Pierre, J., Jacquemin‐Sablon, A., Saucier, J.-M., Pecq, J. B. L., & Larsen, A. K. (1989) · PubMed · Cited by 550
Cleavage of DNA by mammalian DNA topoisomerase II.
Liu, L. F., Rowe, T. C., Yang, L., Tewey, K. M., & Chen, G. L. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43815-4 · Cited by 533
Etoposide, Topoisomerase II and Cancer
Baldwin, E., & Osheroff, N. (2005) · Current Medicinal Chemistry-Anti-Cancer Agents · doi:10.2174/1568011054222364 · Cited by 520
Self-citationTumor Cell Death Induced by Topoisomerase-Targeting Drugs
Li, T.-K., & Liu, L. F. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.53 · Cited by 508
Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme
Burden, D. A., & Osheroff, N. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00132-8 · Cited by 503
Self-citationWoessner, R. D., Mattern, M. R., Mirabelli, C. K., Johnson, R. K., & Drake, F. H. (1991) · PubMed · Cited by 455
Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.
D’Arpa, P., Beardmore, C., & Liu, L. F. (1990) · PubMed · Cited by 425
Secondary leukemias induced by topoisomerase-targeted drugs
Felix, C. A. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00139-0 · Cited by 418
Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II
Drake, F. H., Hofmann, G. A., Bartus, H. F., Mattern, M. R., Crooke, S. T., & Mirabelli, C. K. (1989) · Biochemistry · doi:10.1021/bi00446a029 · Cited by 410
Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle.
Heck, M. M., Hittelman, W. N., & Earnshaw, W. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.4.1086 · Cited by 409
DNA topoisomerase II, genotoxicity, and cancer
McClendon, A. K., & Osheroff, N. (2007) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2007.06.009 · Cited by 406
Self-citationAravind, L. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.18.4205 · Cited by 401
Levine, C., Hiasa, H., & Marians, K. J. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00126-2 · Cited by 391
Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia
Strick, R., Strissel, P. L., Borgers, S., Smith, S. L., & Rowley, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070061297 · Cited by 390
Tsai-Pflugfelder, M., Liu, L. F., Liu, A. A., Tewey, K. M., Whang-Peng, J., Knutsen, T., Huebner, K., Croce, C. M., & Wang, J. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.19.7177 · Cited by 389
Conformational and thermodynamic properties of supercoiled DNA
Vologodskii, A. V., Levene, S. D., Klenin, K. V., Frank-Kamenetskii, M., & Cozzarelli, N. R. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90533-p · Cited by 381
Topoisomerase II as a target for anticancer drugs: When enzymes stop being nice
Fortune, J. M., & Osheroff, N. (2000) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(00)64006-0 · Cited by 366
Self-citationMechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer
Coley, H. M. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.01.007 · Cited by 351
DNA Topoisomerase IIβ and Neural Development
Yang, X., Li, W., Prescott, E. D., Burden, S. J., & Wang, J. C. (2000) · Science · doi:10.1126/science.287.5450.131 · Cited by 344
Investigating the biological functions of DNA topoisomerases in eukaryotic cells
Nitiss, J. L. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00128-6 · Cited by 321
DNA polymerases and human disease
Loeb, L. A., & Monnat, R. J. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2345 · Cited by 320
Roca, J., & Wang, J. C. (1992) · Cell · doi:10.1016/0092-8674(92)90558-t · Cited by 317
Fluoroquinolones: Action and Resistance
Drlica, K., & Malik, M. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452537 · Cited by 317
Structural basis for gate-DNA recognition and bending by type IIA topoisomerases
Dong, K. C., & Berger, J. M. (2007) · Nature · doi:10.1038/nature06396 · Cited by 316
Protection against breast cancer with genistein: a component of soy
Lamartiniere, C. A. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.6.1705s · Cited by 314
Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies
Azarova, A. M., Lyu, Y. L., Lin, C.-P., Tsai, Y.-C., Lau, J. Y.-N., Wang, J. C., & Liu, L. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704002104 · Cited by 286
Double strand DNA cleavage by type II DNA topoisomerase from Drosophila melanogaster.
Sander, M., & Hsieh, T. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82081-x · Cited by 285
DNA Topoisomerase II in Therapy-Related Acute Promyelocytic Leukemia
Mistry, A. R., Felix, C. A., Whitmarsh, R. J., Mason, A., Reiter, A., Cassinat, B., Parry, A., Walz, C., Wiemels, J. L., Segal, M. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042715 · Cited by 281
Self-citationCell death induced by topoisomerase-targeted drugs: more questions than answers
Kaufmann, S. H. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00136-5 · Cited by 278
Drake, F., Zimmerman, J., McCabe, F., Bartus, H., Per, Sr., Sullivan, D., Ross, W., Mattern, M., Johnson, R., & Crooke, S. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49317-9 · Cited by 277
Flavonoids as DNA Topoisomerase Antagonists and Poisons: Structure-Activity Relationships
Constantinou, A., Mehta, R., Runyan, C., Rao, K., Vaughan, A., & Moon, R. (1995) · Journal of Natural Products · doi:10.1021/np50116a009 · Cited by 275
The Molecular Basis of Leukemia
Gilliland, D. G., Jordan, C. T., & Felix, C. A. (2004) · Hematology · doi:10.1182/asheducation-2004.1.80 · Cited by 273
Chung, T. D., Drake, F. H., Tan, K. B., Per, S. R., Crooke, S. T., & Mirabelli, C. K. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9431 · Cited by 248
Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells.
Hsiang, Y. H., Wu, H. Y., & Liu, L. F. (1988) · PubMed · Cited by 247
Paracetamol: Past, Present, and Future
Prescott, L. F. (2000) · American Journal of Therapeutics · doi:10.1097/00045391-200007020-00011 · Cited by 233
Human DNA topoisomerase I: relaxation, roles, and damage control
Leppard, J. B., & Champoux, J. J. (2005) · Chromosoma · doi:10.1007/s00412-005-0345-5 · Cited by 233
Ross, J. A., Potter, J. D., Reaman, G. H., Pendergrass, T. W., & Robison, L. L. (1996) · Cancer Causes and Control · doi:10.1007/bf00051700 · Cited by 219
Eukaryotic topoisomerase II. Characterization of enzyme turnover.
Osheroff, N. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67607-0 · Cited by 206
Self-citationSpector, L. G., Xie, Y., Robison, L. L., Heerema, N. A., Hilden, J. M., Lange, B., Felix, C. A., Davies, S. M., Slavin, J., Potter, J. D., et al. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0602 · Cited by 200
Dynamics of human DNA topoisomerases IIα and IIβ in living cells
Christensen, M. O., Larsen, M. K., Barthelmes, H. U., Hock, R., Andersen, C. L., Kjeldsen, E., Knudsen, B. R., Westergaard, O., Boege, F., & Mielke, C. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200112023 · Cited by 199
Leukemias related to treatment with DNA topoisomerase II inhibitors*
Felix, C. A. (2001) · Medical and Pediatric Oncology · doi:10.1002/mpo.1125 · Cited by 191
Type II Topoisomerases as Targets for Quinolone Antibacterials Turning Dr. Jekyll into Mr. Hyde
Anderson, V., & Osheroff, N. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013398013 · Cited by 190
Self-citationPhysiological regulation of eukaryotic topoisomerase II
Isaacs, R. J., Davies, S. L., Sandri, M. I., Redwood, C., Wells, N. J., & Hickson, I. D. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00131-6 · Cited by 186
Role of Topoisomerase IIβ in the Expression of Developmentally Regulated Genes
Lyu, Y. L., Lin, C.-P., Azarova, A. M., Cai, L., Wang, J. C., & Liu, L. F. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00617-06 · Cited by 179
Yeast DNA topoisomerase II is encoded by a single-copy, essential gene
Goto, T., & Wang, J. C. (1984) · Cell · doi:10.1016/0092-8674(84)90057-6 · Cited by 176
Human Topoisomerase IIα Rapidly Relaxes Positively Supercoiled DNA
McClendon, A. K., Rodriguez, A. C., & Osheroff, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503320200 · Cited by 176
Self-citationBeese, L. S., Friedman, J. M., & Steitz, T. A. (1993) · Biochemistry · doi:10.1021/bi00214a004 · Cited by 170
Austin, C. A., Patel, S., Ono, K., Nakane, H., & Fisher, L. M. (1992) · Biochemical Journal · doi:10.1042/bj2820883 · Cited by 170
Goto, T., & Wang, J. C. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83859-0 · Cited by 168
Bioflavonoids as Poisons of Human Topoisomerase IIα and IIβ
Bandele, O. J., & Osheroff, N. (2007) · Biochemistry · doi:10.1021/bi7000664 · Cited by 167
Self-citationOn the coupling between ATP usage and DNA transport by yeast DNA topoisomerase II.
Lindsley, J. E., & Wang, J. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53067-2 · Cited by 159
Frydman, B., Marton, L. J., Sun, J. S., Neder, K., Witiak, D. T., Liu, A. A., Wang, H. M., Mao, Y., Wu, H., Sanders, M. M., et al. (1997) · PubMed · Cited by 152
Stimulation of Topoisomerase II-Mediated DNA Damage via a Mechanism Involving Protein Thiolation
Wang, H., Mao, Y., Chen, A. Y., Zhou, N., LaVoie, E. J., & Liu, L. F. (2001) · Biochemistry · doi:10.1021/bi002786j · Cited by 152
Burden, D. A., Kingma, P. S., Froelich-Ammon, S. J., Bjornsti, M., Patchan, M. W., Thompson, R. B., & Osheroff, N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29238 · Cited by 149
Self-citationThe Role of Genistein and Synthetic Derivatives of Isoflavone in Cancer Prevention and Therapy
Sarkar, F. H., Adsule, S., Padhyé, S., Kulkarni, S., & Li, Y. (2006) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955706776361439 · Cited by 148
Infant Leukemia, Topoisomerase II Inhibitors, and the MLL Gene
Ross, J. A., Potter, J. D., & Robison, L. L. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.22.1678 · Cited by 147
A Two-drug Model for Etoposide Action against Human Topoisomerase IIα
Bromberg, K. D., Burgin, A. B., & Osheroff, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212056200 · Cited by 145
Self-citationTopoisomerase II and the etiology of chromosomal translocations
Felix, C. A., Kolaris, C. P., & Osheroff, N. (2006) · DNA repair · doi:10.1016/j.dnarep.2006.05.031 · Cited by 145
Self-citationDNA Topoisomerase II as a Target for Cancer Chemotherapy
Walker, J. V., & Nitiss, J. L. (2002) · Cancer Investigation · doi:10.1081/cnv-120002156 · Cited by 139
Beneficial effects of tea and its polyphenols against prostate cancer
Siddiqui, I. A., Adhami, V. M., Saleem, M., & Mukhtar, H. (2006) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500113 · Cited by 134
Hande, K. R. (2006) · Update on Cancer Therapeutics · doi:10.1016/j.uct.2006.04.001 · Cited by 131
ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children
Felix, C., Hosler, M. R., Winick, N., Masterson, M., Wilson, A., & Lange, B. (1995) · Blood · doi:10.1182/blood.v85.11.3250.bloodjournal85113250 · Cited by 129
Zechiedrich, L., Christiansen, K., Andersen, A. H., Westergaard, O., & Osheroff, N. (1989) · Biochemistry · doi:10.1021/bi00441a014 · Cited by 126
Self-citationBandele, O. J., Clawson, S. J., & Osheroff, N. (2008) · Chemical Research in Toxicology · doi:10.1021/tx8000785 · Cited by 123
Self-citationA common topology for bacterial and eukaryotic transcription initiation?
TRAVERS, A. A., & Muskhelishvili, G. (2007) · EMBO Reports · doi:10.1038/sj.embor.7400898 · Cited by 117
DNA sequence selectivity of topoisomerases and topoisomerase poisons
Capranico, G., & Binaschi, M. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00135-3 · Cited by 116
Berger, J. M., & Schoeffler, A. J. (2005) · Biochemical Society Transactions · doi:10.1042/bst20051465 · Cited by 112
Structural similarities between topoisomerases that cleave one or both DNA strands
Berger, J. M., Fass, D., Wang, J. C., & Harrison, S. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7876 · Cited by 110
Untangling intracellular DNA topology
Espéli, O., & Marians, K. J. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04047.x · Cited by 110
Dietary flavonoids and the MLL gene: A pathway to infant leukemia?
Ross, J. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.9.4411 · Cited by 109
Sabourin, M., & Osheroff, N. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.9.1947 · Cited by 105
Self-citationApurinic Sites Are Position-specific Topoisomerase II Poisons
Kingma, P. S., & Osheroff, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.2.1148 · Cited by 100
Self-citationNoble, C. G., & Maxwell, A. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00049-9 · Cited by 98
Sehested, M., Jensen, P. B., Sørensen, B. S., Holm, B., Friche, E., & Demant, E. J. F. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90514-w · Cited by 91
The response of eukaryotic topoisomerases to DNA damage
Kingma, P. S., & Osheroff, N. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00138-9 · Cited by 82
Self-citationHasan, S. K., Mays, A. N., Ottone, T., Ledda, A., Nasa, G. L., Cattaneo, C. M., Borlenghi, E., Melillo, L. M. A., Montefusco, E., Cervera, J., et al. (2008) · Blood · doi:10.1182/blood-2007-10-115600 · Cited by 80
Self-citationInterfacial Inhibitors of Protein-Nucleic Acid Interactions
Pommier, Y. G., & Marchand, C. (2005) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011054222337 · Cited by 74
N-Acetyl-p-benzoquinone Imine, the Toxic Metabolite of Acetaminophen, Is a Topoisomerase II Poison
Bender, R. P., Lindsey, R. H., Burden, D. A., & Osheroff, N. (2004) · Biochemistry · doi:10.1021/bi036107r · Cited by 70
Self-citationSpontaneous DNA Damage Stimulates Topoisomerase II-mediated DNA Cleavage
Kingma, P. S., & Osheroff, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.7488 · Cited by 62
Self-citationHuman topoisomerase II uses a two-metal-ion mechanism for DNA cleavage
Deweese, J. E., Burgin, A. B., & Osheroff, N. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn466 · Cited by 61
Self-citationBandele, O. J., & Osheroff, N. (2008) · Biochemistry · doi:10.1021/bi800981j · Cited by 60
Self-citationKuo, M., Shiah, S., Wang, C., & Chuang, S. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23186-2 · Cited by 56
Khan, Q. A., Kohlhagen, G., Marshall, R., Austin, C. A., Kalena, G. P., Kroth, H., Sayer, J. M., Jerina, D. M., & Pommier, Y. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2032456100 · Cited by 41
Combination therapies in multiple sclerosis
Gold, R. (2008) · Journal of Neurology · doi:10.1007/s00415-008-1008-2 · Cited by 37
DNA Abasic Lesions in a Different Light: Solution Structure of an Endogenous Topoisomerase II Poison
Cline, S. D., Jones, W. R., Stone, M. P., & Osheroff, N. (1999) · Biochemistry · doi:10.1021/bi991750s · Cited by 36
Self-citationBauer, W. R., Crick, F. H., & White, J. H. (1980) · PubMed · Cited by 36
Vélez-Cruz, R., Riggins, J. N., Daniels, J. S., Cai, H., Guengerich, F. P., Marnett, L. J., & Osheroff, N. (2005) · Biochemistry · doi:10.1021/bi0478289 · Cited by 35
Self-citationCurley, J. F., Joyce, C. M., & Piccirilli, J. A. (1997) · Journal of the American Chemical Society · doi:10.1021/ja972014j · Cited by 35
Molecular and Structural Transactions at Human DNA Replication Origins
Falaschi, A., Abdurashidova, G., Sandoval, O., Radulescu, S., Biamonti, G., & Riva, S. (2007) · Cell Cycle · doi:10.4161/cc.6.14.4495 · Cited by 34
Cline, S. D., & Osheroff, N. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.29740 · Cited by 33
Self-citationGene Expression Needs a Break to Unwind Before Carrying On
Haince, J.-F., Rouleau, M., & Poirier, G. G. (2006) · Science · doi:10.1126/science.1129808 · Cited by 30
Coupling between ATP Binding and DNA Cleavage by DNA Topoisomerase II
Mueller‐Planitz, F., & Herschlag, D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710014200 · Cited by 30
Leontiou, C., Lakey, J. H., Lightowlers, R. N., Turnbull, R. M., & Austin, C. A. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015933 · Cited by 23
DNA Topoisomerases as Targets for the Chemotherapeutic Treatment of Cancer
Bender, R. P., & Osheroff, N. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-274-8_3 · Cited by 20
Self-citationPositioning the 3′-DNA Terminus for Topoisomerase II-mediated Religation
Wilstermann, A. M., & Osheroff, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100197200 · Cited by 14
Self-citation
Cited by
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Pommier, Y., Leo, E., Zhang, H., & Marchand, C. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.04.012 · Cited by 1,829
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282
Self-citationRoles of eukaryotic topoisomerases in transcription, replication and genomic stability
Pommier, Y., Sun, Y., Huang, S.-Y. N., & Nitiss, J. L. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.111 · Cited by 950
Drugging Topoisomerases: Lessons and Challenges
Pommier, Y. (2013) · ACS Chemical Biology · doi:10.1021/cb300648v · Cited by 839
H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy
Podhorecka, M., Skladanowski, A., & Bozko, P. (2010) · Journal of Nucleic Acids · doi:10.4061/2010/920161 · Cited by 612
Metadata
- Authors
- Deweese, J. E., & Osheroff, N.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-11-28
- Volume
- 37
- Issue
- 3
- Pages
- 738-748
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W1985550031
- Cited by
- 462
- References
- 109
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.